SQZ BIOTECHNOLOGIES CO (SQZ) Stock Analyst Ratings
USA - NYSE:SQZ - US78472W1045 - Common Stock
0.435 USD
+0.16 (+61.11%)
0.4384 USD
+0 (+0.78%)
ChartMill assigns a Buy % Consensus number of 77% to SQZ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.38. This target is 4355.17% above the current price.
SQZ was analyzed by 6 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about SQZ.
In the previous month the buy percentage consensus was at a similar level.
SQZ was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-12-02 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-12-01 | Chardan Capital | Maintains | Buy |
| 2022-12-01 | B of A Securities | Downgrade | Buy -> Underperform |
| 2022-11-10 | Chardan Capital | Maintains | Buy |
| 2022-10-20 | HC Wainwright & Co. | Initiate | Buy |
| 2022-10-06 | BTIG | Maintains | Buy |
| 2022-05-25 | Chardan Capital | Initiate | Buy |
SQZ BIOTECHNOLOGIES CO / SQZ FAQ
Can you provide the average price target for SQZ BIOTECHNOLOGIES CO stock?
6 analysts have analysed SQZ and the average price target is 19.38 USD. This implies a price increase of 4355.17% is expected in the next year compared to the current price of 0.435.
What is the consensus rating for SQZ stock?
The consensus rating for SQZ BIOTECHNOLOGIES CO (SQZ) is 76.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.